
Pharma Pulse 6/21/24: Improving Access to Trials Through Decentralization & Flexible Design, South Africa Runs Out of Insulin Pens & more
The latest news for pharma industry insiders.
Breakout session discusses the impact of incorporating decentralized elements into oncology clinical trials on data integrity, patient safety, and regulatory approvals.
For Pride Month, Pharmacy Times interviewed Olivia Buckoski, PharmD, AAHIVP, HIVPCP, clinical pharmacist, Western North Carolina Community Health Services, to discuss gender-affirming care for patients in the LGBTQ+ community, what it looks like, and the importance of catering care to the individual. This patient population often face stigma, a lack of cultural competency among providers, and discrimination; however, pharmacists and health care professionals can help by creating a supportive environment for patients.
Do you know what challenges are encountered by sites when operationalizing study protocols? In this webinar, learn how specific protocol design elements impact sites’ perception of burden and how this information can be used to improve site experience.
The shortage highlights a widening gulf in the standard of care for people with diabetes, most of whom live in low-income countries.
QPS is pleased to announce new clinical research operations leadership. This new clinical leadership will further align the existing global medical affairs, regulatory affairs, data services, and clinical operations units with the existing successful QPS Phase I clinics. The enhanced global capabilities will help QPS satisfy the need for agility, flexibility, and speed in the quickly evolving global drug development community.
Sharing insights from interviewing hundreds of exceptional pharma leaders. Want to know what they do differently? Enjoy my short article published today in Pharmaceutical Executive
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor 
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

